Biostage, Inc., a biotechnology company with successful “first-in-human” experience in esophageal cancer and FDA approval to commence a clinical trial of its Biostage Esophageal Implant for esophageal disease, announced the publication of paper establishing the basis for using its product to treat birth defects in the esophagus in babies.
January 10, 2022
· 6 min read